Critical Role for Lysine 685 in Gene Expression Mediated by Transcription Factor Unphosphorylated STAT3

被引:48
|
作者
Dasgupta, Maupali [1 ]
Unal, Hamiyet [2 ]
Willard, Belinda [3 ]
Yang, Jinbo [1 ,4 ]
Karnik, Sadashiva S. [2 ]
Stark, George R. [1 ]
机构
[1] Cleveland Clin, Dept Mol Genet, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA
[3] Cleveland Clin, Mass Spectrometry Lab Prot Sequencing, Lerner Res Inst, Cleveland, OH 44195 USA
[4] Lanzhou Univ, Sch Life Sci, Lanzhou 73000, Gansu, Peoples R China
基金
美国国家卫生研究院;
关键词
ACTIVATES TRANSCRIPTION; SERINE PHOSPHORYLATION; ACETYLATION; METHYLATION; INHIBITION; CELLS; DNA; INDUCTION; COMPLEX; BINDING;
D O I
10.1074/jbc.M114.603894
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
STAT3 is a pleiotropic transcription factor that is activated by the phosphorylation of tyrosine 705 in response to many cytokines and growth factors. STAT3 without Tyr-705 phosphorylation (U-STAT3) is also a potent transcription factor, and its concentration in cells increases greatly in response to STAT3 activation because the STAT3 gene can be driven by phosphorylated STAT3 dimers. We have now searched for post-translational modifications of U-STAT3 that might have a critical role in its function. An analysis by mass spectroscopy indicated that U-STAT3 is acetylated on Lys-685, and the integrity of Lys-685 is required for the expression of most U-STAT3-dependent genes. In contrast, we found only a very minor role for Lys-685 in gene expression induced in response to tyrosine-phosphorylated STAT3. U-STAT3 plays an important role in angiotensin II-induced gene expression and in the consequent development of cardiac hypertrophy and dysfunction. Mutation of Lys-685 inhibits this function of STAT3, providing new information on the role of U-STAT3 in augmenting the development of heart failure.
引用
收藏
页码:30763 / 30771
页数:9
相关论文
共 50 条
  • [31] STAT3 gene expression in ameloblastomas and odontogenic keratocysts
    Melo, Leonardo de Araujo
    de Santana, Dandara Andrade
    Sales, Caroline Brandi Schlaepfer
    Carneiro Jr, Braulio
    Martins, Marilia Trierveiler
    Freitas, Valeria Souza
    Xavier, Flavia Calo Aquino
    Cury, Patricia Ramos
    Gurgel, Clarissa Araujo Silva
    dos Santos, Jean Nunes
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2023, 151 (1-2) : 15 - 20
  • [32] Critical Role of STAT3 in IL-6-Mediated Drug Resistance in Human Neuroblastoma
    Ara, Tasnim
    Nakata, Rie
    Sheard, Michael A.
    Shimada, Hiroyuki
    Buettner, Ralf
    Groshen, Susan G.
    Ji, Lingyun
    Yu, Hua
    Jove, Richard
    Seeger, Robert C.
    DeClerck, Yves A.
    CANCER RESEARCH, 2013, 73 (13) : 3852 - 3864
  • [33] Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression
    Benkhart, EM
    Siedlar, M
    Wedel, A
    Werner, T
    Ziegler-Heitbrock, HWL
    JOURNAL OF IMMUNOLOGY, 2000, 165 (03): : 1612 - 1617
  • [34] Epigenetic regulation of transcription factor STAT3 activity in cancer cells
    Sehgal, Pravin B.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (08): : 373 - 377
  • [35] Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
    Lee, David S.
    O'Keefe, Rachel A.
    Ha, Patrick K.
    Grandis, Jennifer R.
    Johnson, Daniel E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06):
  • [36] Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
    Xiong, Ailian
    Yang, Zhengduo
    Shen, Yicheng
    Zhou, Jia
    Shen, Qiang
    CANCERS, 2014, 6 (02) : 926 - 957
  • [37] STAT3 transcription factor as target for anti-cancer therapy
    Aliaa M. Mohassab
    Heba A. Hassan
    Dalia Abdelhamid
    Mohamed Abdel-Aziz
    Pharmacological Reports, 2020, 72 : 1101 - 1124
  • [38] Transcription factor Stat3 promotes metastatic progression of prostate cancer
    Gu, Lei
    Abdulghani, Junaid
    Dagvadorj, Ayush
    Lutz, Jacqueline
    Bonuccelli, Gloria
    Lisanti, Michael P.
    Zellweger, Tobias
    Alanen, Kalle
    Mirtti, Tuomas
    Visakorpi, Tapio
    Bubendorf, Lukas
    Nevalainen, Marja T.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 392 - 392
  • [39] STAT3 transcription factor as target for anti-cancer therapy
    Mohassab, Aliaa M.
    Hassan, Heba A.
    Abdelhamid, Dalia
    Abdel-Aziz, Mohamed
    PHARMACOLOGICAL REPORTS, 2020, 72 (05) : 1101 - 1124
  • [40] Transcription Factor STAT3 As a Prognostic Marker and Therapeutic Target in Cancer
    Frank, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (36) : 4560 - 4561